| 05/01/2026 3:17 PM | BioRestorative Therapies (1505497) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/28/2026 11:15 PM | BioRestorative Therapies (1505497) Filer | Form EFFECT | |
| 04/27/2026 3:05 PM | BioRestorative Therapies (1505497) Filer | Form POS AM | |
| 04/23/2026 4:12 PM | BioRestorative Therapies (1505497) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/20/2026 4:30 PM | BioRestorative Therapies (1505497) Filer | Form POS AM | |
| 04/13/2026 4:22 PM | BioRestorative Therapies (1505497) Filer | Form DEF 14A | |
| 04/03/2026 1:46 PM | BioRestorative Therapies (1505497) Filer | Form PRE 14A | |
| 03/26/2026 3:20 PM | BioRestorative Therapies (1505497) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 02/23/2026 3:50 PM | BioRestorative Therapies (1505497) Subject Morrison Todd Hale (2027680) Filed by | Form SCHEDULE 13G/A | |
| 02/18/2026 3:12 PM | BioRestorative Therapies (1505497) Subject INTRACOASTAL CAPITAL, LLC (1646799) Filed by | Form SCHEDULE 13G | |
| 02/17/2026 1:16 PM | Auctus Fund Management LLC (1700205) Filed by BioRestorative Therapies (1505497) Subject | Form SCHEDULE 13G/A | |
Get the Latest News and Ratings for BRTXQ and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for BioRestorative Therapies and its competitors with MarketBeat's FREE daily newsletter.
|
| 02/13/2026 8:48 AM | BioRestorative Therapies (1505497) Filer | Form 424B4 | |
| 02/11/2026 11:15 PM | BioRestorative Therapies (1505497) Filer | Form EFFECT | |
| 02/09/2026 4:31 PM | BioRestorative Therapies (1505497) Filer | Form S-1 Registration statement under Securities Act of 1933 | |
| 12/19/2025 2:06 PM | BioRestorative Therapies (1505497) Subject Morrison Todd Hale (2027680) Filed by | Form SCHEDULE 13G/A | |
| 12/12/2025 4:11 PM | BioRestorative Therapies (1505497) Filer | Form 424B3 | |
| 12/10/2025 11:15 PM | BioRestorative Therapies (1505497) Filer | Form EFFECT | |
| 11/18/2025 3:45 PM | BioRestorative Therapies (1505497) Filer | Form S-1 Registration statement under Securities Act of 1933 | |
| 11/18/2025 3:48 PM | BioRestorative Therapies (1505497) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 10/20/2025 7:18 AM | BioRestorative Therapies (1505497) Issuer Silva Francisco (1527241) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/20/2025 7:02 AM | ALSTODT LANCE (1756228) Reporting BioRestorative Therapies (1505497) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/09/2025 11:50 AM | BioRestorative Therapies (1505497) Filer | Form D Notice of Exempt Offering of Securities | |
| 10/08/2025 4:10 PM | BioRestorative Therapies (1505497) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/08/2025 3:25 PM | BioRestorative Therapies (1505497) Filer | Form 424B5 | |
| 10/06/2025 10:55 AM | BioRestorative Therapies (1505497) Filer | Form 424B5 | |
| 09/25/2025 10:49 AM | BioRestorative Therapies (1505497) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/14/2025 4:08 PM | BioRestorative Therapies (1505497) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/14/2025 2:12 PM | Auctus Fund Management LLC (1700205) Filed by BioRestorative Therapies (1505497) Subject | Form SCHEDULE 13G/A | |
| 08/12/2025 3:30 PM | BioRestorative Therapies (1505497) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 08/12/2025 3:16 PM | BioRestorative Therapies (1505497) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/08/2025 4:10 PM | BioRestorative Therapies (1505497) Filer | Form DEF 14A | |
| 06/13/2025 7:31 AM | BioRestorative Therapies (1505497) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |